INSM
Insmed Inc
117.80$
-3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.8% | -9.8% | +19.7% | +3.4% | +11.8% | -11.1% | +15.7% | +32.5% | +85.4% | +16.0% | +39.1% | – | |
| – | +10.4% | -5.3% | +20.1% | +1.0% | +23.5% | -18.6% | +31.9% | +4.6% | +50.6% | +11.9% | +35.8% | – | |
| – | +4.6% | -11.0% | +19.5% | +4.1% | +8.4% | -8.6% | +10.9% | +42.4% | +94.4% | +16.8% | +39.7% | – | |
| – | +25.5% | -11.6% | +21.2% | +2.8% | +19.2% | -15.1% | +16.1% | +5.2% | +36.7% | -17.8% | +0.3% | – | |
| – | -1.2% | +4.0% | +14.5% | +11.6% | +19.8% | +3.5% | +4.9% | +20.4% | +14.0% | +16.4% | +0.1% | – | |
| – | +15.9% | -16.4% | +76.0% | -20.3% | +8.1% | +3.6% | +22.7% | +22.1% | -2.0% | -2.7% | -21.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.4% | +1.2% | +1.1% | -1.0% | +2.4% | +0.1% | -1.5% | -4.1% | +1.1% | -2.5% | +1.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +83.5% | -41.0% | +42.3% | +21.0% | +24.9% | -28.0% | +36.3% | +6.2% | +17.5% | -5.5% | +27.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.